- Home
- EMBC vs RERE Comparison
EMBC vs RERE Comparison
Compare EMBC & RERE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- EMBC
- RERE
- Stock Information
- Founded
- EMBC 1924
- RERE 2011
- Country
- EMBC United States
- RERE China
- Employees
- EMBC N/A
- RERE N/A
- Industry
- EMBC Medical/Dental Instruments
- RERE Other Specialty Stores
- Sector
- EMBC Health Care
- RERE Consumer Discretionary
- Exchange
- EMBC Nasdaq
- RERE Nasdaq
- Market Cap
- EMBC 782.5M
- RERE 932.6M
- IPO Year
- EMBC N/A
- RERE 2021
- Fundamental
- Price
- EMBC $13.66
- RERE $3.75
- Analyst Decision
- EMBC Buy
- RERE
- Analyst Count
- EMBC 2
- RERE 0
- Target Price
- EMBC $18.50
- RERE N/A
- AVG Volume (30 Days)
- EMBC 310.8K
- RERE 1.5M
- Earning Date
- EMBC 11-25-2025
- RERE 11-19-2025
- Dividend Yield
- EMBC 4.42%
- RERE N/A
- EPS Growth
- EMBC 18.26
- RERE N/A
- EPS
- EMBC 1.42
- RERE 0.12
- Revenue
- EMBC $1,102,500,000.00
- RERE $2,588,775,650.00
- Revenue This Year
- EMBC N/A
- RERE $30.66
- Revenue Next Year
- EMBC N/A
- RERE $25.12
- P/E Ratio
- EMBC $9.56
- RERE $31.35
- Revenue Growth
- EMBC N/A
- RERE 27.39
- 52 Week Low
- EMBC $9.20
- RERE $2.00
- 52 Week High
- EMBC $21.48
- RERE $4.93
- Technical
- Relative Strength Index (RSI)
- EMBC 41.91
- RERE 36.96
- Support Level
- EMBC $13.93
- RERE $3.78
- Resistance Level
- EMBC $14.43
- RERE $4.35
- Average True Range (ATR)
- EMBC 0.48
- RERE 0.20
- MACD
- EMBC -0.03
- RERE -0.02
- Stochastic Oscillator
- EMBC 23.59
- RERE 0.00
About EMBC Embecta Corp.
Embecta Corp is a medical device company focused on providing solutions to improve the health and well-being of people living with diabetes. It has a broad portfolio of marketed products, including various pen needles, syringes, and safety devices, which are complemented by a proprietary digital application designed to assist people with managing their diabetes. The company predominantly sells products to wholesalers and distributors that sell to retail and institutional channels who in turn sell to patients or use the products to deliver insulin injections to patients. It also provides contract manufacturing services. Geographically, the company derives a majority of its revenue from the United States.
About RERE ATRenew Inc.
ATRenew Inc is a pre-owned consumer electronics transactions and services platform in China. The majority of its revenue is derived from online product sales of phones and other consumer electronics goods through its platform. The Company's principal operations and geographic markets are in the People's Republic of China.